These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33872293)

  • 1. Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn Disease?
    D'Arcangelo G; Imondi C; Terrin G; Catassi G; Aloi M
    J Pediatr Gastroenterol Nutr; 2021 Aug; 73(2):242-246. PubMed ID: 33872293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn's Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography.
    Arai T; Takeuchi K; Miyamura M; Ishikawa R; Yamada A; Katsumata M; Igarashi Y; Suzuki Y
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):56-62. PubMed ID: 27565523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Calprotectin More Accurately Predicts Endoscopic Remission of Crohn's Disease than Serological Biomarkers Evaluated Using Balloon-assisted Enteroscopy.
    Kawashima K; Ishihara S; Yuki T; Fukuba N; Sonoyama H; Kazumori H; Yamashita N; Tada Y; Kusunoki R; Oka A; Oshima N; Mishima Y; Moriyama I; Kinoshita Y
    Inflamm Bowel Dis; 2017 Nov; 23(11):2027-2034. PubMed ID: 28817462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Calprotectin in Ileal Crohn's Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score.
    Cerrillo E; Beltrán B; Pous S; Echarri A; Gallego JC; Iborra M; Pamies J; Nos P
    Inflamm Bowel Dis; 2015 Jul; 21(7):1572-9. PubMed ID: 26052967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy.
    Iwamoto F; Matsuoka K; Motobayashi M; Takenaka K; Kuno T; Tanaka K; Tsukui Y; Kobayashi S; Yoshida T; Fujii T; Saito E; Yamaguchi T; Nagahori M; Sato T; Ohtsuka K; Enomoto N; Watanabe M
    J Gastroenterol Hepatol; 2018 Dec; 33(12):1984-1989. PubMed ID: 29889986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Calprotectin as a Selection Tool for Small Bowel Capsule Endoscopy in Suspected Crohn's Disease.
    Monteiro S; Barbosa M; Cúrdia Gonçalves T; Boal Carvalho P; Moreira MJ; Rosa B; Cotter J
    Inflamm Bowel Dis; 2018 Aug; 24(9):2033-2038. PubMed ID: 29722829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin predicts endoscopic activity and mucosal healing of small bowel Crohn's disease evaluated by double-balloon endoscopy.
    Han W; Wu J; Zhang P; Hu N; Mei Q; Hu J
    Int J Colorectal Dis; 2022 Sep; 37(9):1953-1961. PubMed ID: 35927341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location.
    Buisson A; Mak WY; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
    Inflamm Bowel Dis; 2021 Jun; 27(7):1008-1016. PubMed ID: 33107563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease.
    Farias E Silva K; Nanini HF; Cascabulho CM; Rosas SLB; Santana PT; Carneiro AJV; Anaissie E; Nucci M; de Souza HSP
    World J Gastroenterol; 2021 Mar; 27(9):866-885. PubMed ID: 33727775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients.
    Cannatelli R; Bazarova A; Zardo D; Nardone OM; Shivaji U; Smith SCL; Gkoutos G; Ricci C; Gui XS; Ghosh S; Iacucci M
    Inflamm Bowel Dis; 2021 Apr; 27(5):647-654. PubMed ID: 32592477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis.
    Kopylov U; Yung DE; Engel T; Avni T; Battat R; Ben-Horin S; Plevris JN; Eliakim R; Koulaouzidis A
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1137-44. PubMed ID: 27415156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal Calprotectin and Magnetic Resonance Enterography in Ileal Crohn's Disease: Correlations Between Disease Activity and Long-Term Follow-Up.
    Jones GR; Fascì-Spurio F; Kennedy NA; Plevris N; Jenkinson P; Lyons M; Wong L; MacLean P; Glancy S; Lees CW
    J Crohns Colitis; 2019 Mar; 13(4):442-450. PubMed ID: 30452618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new simplified MARIA score applies beyond clinical trials: A suitable clinical practice tool for Crohn's disease that parallels a simple endoscopic index and fecal calprotectin.
    Roseira J; Ventosa AR; de Sousa HT; Brito J
    United European Gastroenterol J; 2020 Dec; 8(10):1208-1216. PubMed ID: 32664824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn's Disease Recurrence.
    Cerrillo E; Moret I; Iborra M; Pamies J; Hervás D; Tortosa L; Sáez-González E; Nos P; Beltrán B
    Inflamm Bowel Dis; 2019 Sep; 25(10):1681-1691. PubMed ID: 30925193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease.
    Pous-Serrano S; Frasson M; Cerrillo E; Beltrán B; Iborra M; Hervás D; García-Granero E; Nos P
    J Surg Res; 2017 Jun; 213():290-297. PubMed ID: 28601328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Faecal Calprotectin Levels are a Reliable Non-Invasive Screening Tool for Small Bowel Crohn's Disease in Patients Undergoing Capsule Endoscopy.
    Yousuf H; Aleem U; Egan R; Maheshwari P; Mohamad J; McNamara D
    Dig Dis; 2018; 36(3):202-208. PubMed ID: 29466790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease.
    Shaoul R; Sladek M; Turner D; Paeregaard A; Veres G; Wauters GV; Escher J; Dias JA; Lionetti P; Staino A; Kolho KL; de Ridder L; Nuti F; Cucchiara S; Sheva O; Levine A;
    Inflamm Bowel Dis; 2012 Aug; 18(8):1493-7. PubMed ID: 22275268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of disease location on fecal calprotectin levels in Crohn's disease.
    Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
    Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.
    Sipponen T; Haapamäki J; Savilahti E; Alfthan H; Hämäläinen E; Rautiainen H; Koskenpato J; Nuutinen H; Färkkilä M
    Scand J Gastroenterol; 2012 Jul; 47(7):778-84. PubMed ID: 22519419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.